MENU
DYN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Dyne Therapeutics (DYN) Ownership - Who owns Dyne Therapeutics?
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases... Show more
Industry: #Electric Utilities
Profile
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.52B
P/E Ratio
N/A
Total Cash
677.49M
Projected Growth
N/A
Total Debt
23.33M
Revenue
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
5.96
Total Debt/Equity
92.44
Revenue/Share
null USD as % of share price
Fundamentals
DYN
Capitalization
1.52B
P/E Ratio
N/A
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
677M
Total Cash/Share
5.96
Total Debt
23.3M
Total Debt/Equity
92.44
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
669M
P/B Ratio
2.28
Cash Flow
N/A
Earnings
-3.61
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
11K
Current Ratio
20.35
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-395.31M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-59.05
Shares Held By Institutions
4.65B
Shares Outstanding - Current
114M
Total Liabilities
52.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-43.081
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Electric Utilities
Address
1560 Trapelo Road
Phone
+1 781 786-8230
Employees
141
Web
https://www.dyne-tx.com